Alzheimer's risk lower in IVIg treated patients

THE PHARMACEUTICAL JOURNAL GROUP

首页> 外文期刊>The pharmaceutical journal >Alzheimer's risk lower in IVIg treated patients

【24h】

Alzheimer's risk lower in IVIg treated patients

机译：接受IVIg治疗的患者的阿尔茨海默病风险更低

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Patients who have previously been treated with intravenous immunoglobulin (IVIg) reduce their risk of developing Alzheimer's disease, research published in Neurology (2009;73:180) suggests.

机译：《神经学》（Neurology）（2009; 73：180）上发表的一项研究表明，以前接受过静脉注射免疫球蛋白（IVIg）治疗的患者降低了患阿尔茨海默氏病的风险。

著录项

来源
《The pharmaceutical journal》 |2009年第7562期|共1页
作者
THE PHARMACEUTICAL JOURNAL GROUP;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Alzheimer's risk lower in IVIg treated patients [J] . THE PHARMACEUTICAL JOURNAL GROUP The pharmaceutical journal . 2009,第3a7562期

机译：接受IVIg治疗的患者的阿尔茨海默病风险更低
2. Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS [J] . A F List, J M Bennett, M A Sekeres, Leukemia . 2014,第5期

机译：红血球反应性来那度胺治疗的低风险del（5q）MDS患者的延长生存期并降低AML进展的风险
3. Bleeding, vertebral fractures and vascular calcifications in patients treated with warfarin: hope for lower risks with alternative therapies. [J] . Fusaro M, Crepaldi G, Maggi S, Current vascular pharmacology . 2011,第6期

机译：华法林治疗的患者的出血，椎骨骨折和血管钙化：希望通过其他疗法降低风险。
4. PREDICTING EFFICACY OF IVIG TO LOWER HLA ANTIBODY IN PATIENTS: CORRELATION BETWEEN IN VITRO PREDICTION AND IN VIVO RESULTS USING THE C1Q SAB ASSAY [C] . Dolly Tyan, Ge Chen, Marcelo Pando Clinical Histocompatibility Workshop. . 2010

机译：预测IVIG在患者中降低HLA抗体的功效：使用C1Q SAB测定的体外预测与体内结果之间的相关性
5. Perceived Alzheimer's disease threat as a predictor of behavior change to lower disease risk: The Gray Matters Study. [D] . Clark, Christine. 2016

机译：阿尔茨海默氏病的威胁可以作为行为改变以降低疾病风险的预测指标：灰色问题研究。
6. Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS [O] . A F List, J M Bennett, M A Sekeres, -1

机译：红血球反应性来那度胺治疗的低风险del（5q）MDS患者的延长生存期并降低AML进展的风险
7. 254: Evaluation of cardiovascular risk and excess of risk according to age in high risk primary care patients not treated with lipid-lowering treatment in France [O] . Ferrières Jean, Dallongeville Jean, Kownator Serge, 2013

机译：254：在法国对未接受降脂治疗的高风险初级保健患者的心血管风险和风险风险评估

Alzheimer's risk lower in IVIg treated patients

摘要

著录项

相似文献

相关主题

期刊订阅